Showing results (1-10 of 92) with videos related to
Sort By:
Pageof 10
Cellular and Molecular Life Sciences : CMLS|July 3, 2007
Physiological and pathological properties of alpha-synucleinG K Tofaris, M G SpillantiniFEBS Letters|December 6, 2001
alpha-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasomeG K Tofaris, R Layfield, M G SpillantiniCell Transplantation|August 22, 2007
The effect of truncated human alpha-synuclein (1-120) on dopaminergic cells in a transgenic mouse model of Parkinson's diseaseA W Michell, G K Tofaris, H Gossage, et al.Parkinsonism & Related Disorders|July 2, 2008
Parkinson's disease, dementia with Lewy bodies and multiple system atrophy are alpha-synucleinopathiesM G SpillantiniPharmacology, Biochemistry, and Behavior|May 1, 1986
Inhibition of penicillin-induced EEG discharges by low doses of morphine or naloxone in the rabbit. Evidence for a possible non-opioid receptor-mediated mechanism at the sensorimotor cortexM G Spillantini, M MassottiBiochimica Et Biophysica Acta|July 19, 2000
Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's diseaseM Goedert, M G SpillantiniCellular and Molecular Neurobiology|March 1, 1990
Molecular neuropathology of Alzheimer's disease: in situ hybridization studiesM Goedert, M G SpillantiniTrends in Neurosciences|October 24, 1998
Tau protein pathology in neurodegenerative diseasesM G Spillantini, M GoedertBiochemical Society Symposium|July 13, 2001
Tau gene mutations and neurodegenerationM Goedert, M G SpillantiniAnnals of the New York Academy of Sciences|February 24, 2001
The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophyM G Spillantini, M GoedertPageof 10